Clinical trial
The Effect of Metformin on Clinical Course of Ischemic Etiology Chronic Heart Failure in Patients With Prediabetes: the Open-label Randomized Clinical Trial
NCT04549415 is registered in ClinicalTrials.gov with National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Metformin on Clinical Course of Ischemic Etiology Chronic Heart Failure in Patients With Prediabetes: the Open-label Randomized Clinical Trial
- Lead sponsor
- National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 1, 2018
- Completion date
- November 15, 2019
- Enrollment
- 97 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic heart failure, coronary artery disease, prediabetes